Default: Multiple Sclerosis

ISSN: 1352-4585

Journal Home

Journal Guideline

Multiple Sclerosis Q1 Unclaimed

SAGE Publications Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Multiple Sclerosis is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 147. It has an SJR impact factor of 1,534 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,534.

Multiple Sclerosis focuses its scope in these topics and keywords: multiple, patients, sclerosis, ms, levels, courses, progressive, aquaporin, isolated, syndrome, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


- €

Inmediate OA


Embargoed OA

0 €

Non OA


Multiple Sclerosis


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

multiple, patients, sclerosis, ms, levels, courses, progressive, aquaporin, isolated, syndrome, clinical, relapsing, remyelination, casethe, cortex, contribute, disordersretinal, cerebral, casecontrolled, case, carems, blood, basic, bands, atrophy, association, assay, antimuscarinic,

Best articles by citations

Prognostic factors in multidisciplinary rehabilitation treatment in multiple sclerosis: an outcome study

View more

Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis

View more

Modulation of autoimmune responses by intravenous immunoglobulin (IVIg)

View more

Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls

View more

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E)

View more

Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale

View more

Expression of chemokine receptors in the different clinical forms of multiple sclerosis

View more

Motor determinants of gait in 100 ambulatory patients with multiple sclerosis

View more

Cytokines in multiple sclerosis: pro-inflammation or pro-remyelination?

View more

Failure to Detect Measles Virus Rna, by Reverse Transcription-Polymerase Chain Reaction, in Peripheral Blood Leucocytes of Patients with Multiple Sclerosis

View more

Continuing optic nerve atrophy following optic neuritis: a serial MRI study

View more

Protective personality traits: High openness and low neuroticism linked to better memory in multiple sclerosis

View more

Are we in need of NEDA?

View more

Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60

View more

Multiple sclerosis in childhood: clinical features of 149 cases

View more

Multiple sclerosis patients with and without sexual dysfunction: are there any differences?

View more

A "kissing lesion": In-vivo 7T evidence of meningeal inflammation in early multiple sclerosis

View more

Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome -NO

View more

Viruses in chronic progressive neurologic disease

View more

A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients

View more

Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis

View more

Caffeine and alcohol intakes have no association with risk of multiple sclerosis

View more

Autoreactivity to myelin antigens related to HLA associations with multiple sclerosis

View more

Survival of multiple sclerosis in Finland between 1964 and 1993

View more